home / stock / zntl / zntl quote
Last: | $4.38 |
---|---|
Change Percent: | -4.16% |
Open: | $4.51 |
Close: | $4.57 |
High: | $4.79 |
Low: | $4.21 |
Volume: | 712,151 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.38 | $4.51 | $4.57 | $4.79 | $4.21 | 712,151 | 07-17-2024 |
$4.57 | $4.06 | $4.57 | $4.58 | $3.97 | 1,568,186 | 07-16-2024 |
$3.98 | $3.99 | $3.98 | $4.17 | $3.85 | 895,053 | 07-15-2024 |
$3.97 | $4.03 | $3.97 | $4.27 | $3.83 | 1,366,991 | 07-12-2024 |
$3.98 | $4.05 | $3.98 | $4.17 | $3.91 | 1,279,799 | 07-11-2024 |
$3.94 | $4.24 | $3.94 | $4.2854 | $3.91 | 845,293 | 07-10-2024 |
$4.23 | $4.18 | $4.23 | $4.47 | $4 | 1,249,914 | 07-09-2024 |
$4.18 | $3.62 | $4.18 | $4.26 | $3.6 | 2,913,582 | 07-08-2024 |
$3.62 | $3.49 | $3.62 | $3.655 | $3.27 | 1,343,430 | 07-05-2024 |
$3.48 | $3.61 | $3.48 | $3.72 | $3.46 | 377,900 | 07-04-2024 |
$3.48 | $3.61 | $3.48 | $3.72 | $3.46 | 377,900 | 07-03-2024 |
$3.57 | $4.22 | $3.57 | $4.22 | $3.435 | 1,301,345 | 07-02-2024 |
$4.19 | $4.09 | $4.19 | $4.26 | $4.03 | 1,186,812 | 07-01-2024 |
$4.09 | $4.24 | $4.09 | $4.24 | $3.97 | 3,688,824 | 06-28-2024 |
$4.2 | $4.2 | $4.2 | $4.3 | $4.0097 | 1,052,957 | 06-27-2024 |
$4.16 | $4.19 | $4.16 | $4.19 | $3.99 | 1,483,511 | 06-26-2024 |
$4.2 | $4.6 | $4.2 | $4.8613 | $4.13 | 2,626,259 | 06-25-2024 |
$4.6 | $4.69 | $4.6 | $4.77 | $4.41 | 2,427,833 | 06-24-2024 |
$4.75 | $5 | $4.75 | $5.47 | $4.66 | 4,385,276 | 06-21-2024 |
$5.25 | $4.31 | $5.25 | $5.6999 | $4.1 | 8,060,650 | 06-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Zentalis Pharmaceuticals Inc. Company Name:
ZNTL Stock Symbol:
NASDAQ Market:
Zentalis Pharmaceuticals Inc. Website:
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) is one of today's top gainers. The company's shares have moved 30.16% on the day to $5.39. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatme...
2024-06-20 08:30:04 ET UBS analyst issues NEUTRAL recommendation for ZNTL on June 20, 2024 06:35AM ET. ZNTL was trading at $4.14 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 5 - Buy, 4 - Hold recommend...
A look at the top 10 most actives in the United States Reliance Global Group Inc. (RELI) rose 76.2% to $0.3911 on volume of 383,719,808 shares NLS Pharmaceutics Ltd. (NLSP) rose 82.1% to $0.2701 on volume of 302,290,803 shares NVIDIA Corporation (NVDA) rose 3.5% to $135.58 on volume of 28...